HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparative cardiovascular effects of KRN2391 and other coronary vasodilators in anesthetized open-chest dogs.

Abstract
The effect of KRN2391 [N-cyano-N'-(2-nitroxyethyl)-3-pyridinecarboximidamide monomethanesulfonate] on the cardiovascular system and on myocardial oxygen consumption was compared with that of nicorandil and nifedipine in anesthetized dogs. Intravenous administration of KRN2391 (3-30 micrograms/kg) and nifedipine (1 and 3 micrograms/kg) decreased mean aortic blood pressure and total peripheral vascular resistance, and increased coronary blood flow, cardiac output and stroke volume. Heart rate was not significantly affected by KRN2391, but slightly increased by 1 microgram/kg of nifedipine. Nicorandil (100 and 300 micrograms/kg, intravenously) decreased mean aortic blood pressure, cardiac output, stroke volume and total peripheral vascular resistance, but did not affect heart rate. Nicorandil also showed a tendency to decrease coronary blood flow after an initial increase. All drugs tested decreased the difference in oxygen concentration between arterial and coronary sinus blood, indicating that these drugs increased the oxygen supply to the heart. Myocardial oxygen consumption was significantly decreased by more than 10 micrograms/kg of KRN2391, but was not affected by nifedipine. Nicorandil showed a tendency to decrease the myocardial oxygen consumption, though not significantly. Thus, KRN2391 may be useful to treat ischemic heart disease, because it increases the coronary blood flow and the oxygen supply to the heart, and decreases the afterload and the myocardial oxygen consumption.
AuthorsN Ogawa, S Kaneta, Y Jinno, H Kasai, K Nishikori, H Fukushima
JournalArchives internationales de pharmacodynamie et de therapie (Arch Int Pharmacodyn Ther) 1992 Jul-Aug Vol. 318 Pg. 36-46 ISSN: 0003-9780 [Print] Belgium
PMID1463370 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Pyridines
  • Vasodilator Agents
  • N-cyano-N'-(2-nitroxyethyl)-3-pyridinecarboximidamide methanesulfonate
  • Niacinamide
  • Nicorandil
  • Nifedipine
Topics
  • Anesthesia
  • Animals
  • Blood Flow Velocity (drug effects)
  • Cardiac Output (drug effects)
  • Coronary Circulation (drug effects)
  • Dogs
  • Female
  • Heart Rate (drug effects)
  • Hemodynamics (drug effects)
  • Male
  • Niacinamide (analogs & derivatives, pharmacology)
  • Nicorandil
  • Nifedipine (pharmacology)
  • Pyridines (pharmacology)
  • Stroke Volume (drug effects)
  • Vascular Resistance (drug effects)
  • Vasodilator Agents (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: